SEC Form 4 · accession 0000899243-18-018489
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francis E Odonnell Jr.
Director
Period of report
Jun 25, 2018
Accepted (ET)
Jun 27, 2018 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 25, 2018 | M | 37,500 | $2.01 | A | 422,674 | D | |
| Common Stock | Jun 25, 2018 | F | 27,525 | $3.10 | D | 395,149 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $2.01 | Jun 25, 2018 | M | 37,500 | D | Jul 24, 2008 | Jul 24, 2018 | Common Stock | 37,500 | 0 | D |
Explanation of responses
- F1The Reporting Person acquired the shares through a cashless exercise under the Issuer's Amended and Restated 2001 Incentive Plan. The Reporting Person exercised a total of 37,500 options and received 9,975 shares of common stock.